PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients

BACKGROUND: Cancer is a highly heterogeneous disease with varying responses to anti-cancer drugs. Although several attempts have been made to predict the anti-cancer therapeutic responses, there remains a great need to develop highly accurate prediction models of response to the anti-cancer drugs fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Youngchul, Kim, Daewon, Cao, Biwei, Carvajal, Rodrigo, Kim, Minjung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Methodology Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336455/
https://www.ncbi.nlm.nih.gov/pubmed/32631229
http://dx.doi.org/10.1186/s12859-020-03633-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336455/
https://www.ncbi.nlm.nih.gov/pubmed/32631229
http://dx.doi.org/10.1186/s12859-020-03633-z

Ejemplares similares